Cargando…
Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children
BACKGROUND: Artemisinin-based combination treatments (ACTs) or intravenous artesunate are used in over 100 countries for uncomplicated or severe falciparum malaria. Although intravenous artesunate may cause delayed haemolytic anaemia, there is little evaluation of the temporal changes in haematocrit...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620624/ https://www.ncbi.nlm.nih.gov/pubmed/26502714 http://dx.doi.org/10.1186/s12879-015-1219-y |
_version_ | 1782397328571760640 |
---|---|
author | Sowunmi, Akintunde Akano, Kazeem Ayede, Adejumoke I. Ntadom, Godwin Fatunmbi, Bayo Aderoyeje, Temitope Adewoye, Elsie O. |
author_facet | Sowunmi, Akintunde Akano, Kazeem Ayede, Adejumoke I. Ntadom, Godwin Fatunmbi, Bayo Aderoyeje, Temitope Adewoye, Elsie O. |
author_sort | Sowunmi, Akintunde |
collection | PubMed |
description | BACKGROUND: Artemisinin-based combination treatments (ACTs) or intravenous artesunate are used in over 100 countries for uncomplicated or severe falciparum malaria. Although intravenous artesunate may cause delayed haemolytic anaemia, there is little evaluation of the temporal changes in haematocrit following ACTs. METHODS: Clinical and parasitological parameters were measured before and following treatment of uncomplicated falciparum malaria in children with artesunate-amodiaquine (AA) or artemether-lumefantrine (AL) over 6-weeks. Changes in haematocrit were characterized in individual patients based on a haematocrit <30 % or ≥30 % before and following treatment. Kinetics of the deficit in haematocrit from <30 % until attainment of ≥30 % were estimated by a non-compartment model. RESULTS: In 248 of 1180 children eligible for evaluation, common temporal patterns were: no change or increase in haematocrit from ≥ 30 % [50 % of patients], haematocrit >30 % at presentation declining to <30 % within 2 weeks (early monophasic fall) [19 % of patients], and haematocrit <30 % at presentation increasing to ≥ 30 % [23 % of patients]. Haematocrit >30 % at presentation declining to <30 %, 3–5 weeks later (late monophasic fall) occurred in 7 children (3 %). Fall in haematocrit ≥5 units following treatment occurred in 57 children [23 %] between 14 and 28 days after treatment began. Baseline parasitaemia and proportion with > 100,000μL(-1 )asexual forms were significantly higher in children with ≥5 units compared to <5 units fall in haematocrit 21 or 28 days after treatment began. Irrespective of pattern, declines in haematocrit deficit from <30 % were mono-exponential, with similar half-times for AA- and AL-treated children (1.32 d versus 1.14 d). Anaemia half-time correlated significantly positively with anaemia recovery time in the same patients (r = 0.55, P < 0.0001). Bland-Altman analysis of 9 or 10 multiples of anaemia half-time and anaemia recovery times showed narrow limit of agreement with insignificant biases (P = 0.19 or 0.63, respectively). CONCLUSIONS: In uncomplicated falciparum malaria, increases or falls in haematocrit are common following ACTs. Falls in haematocrit ≥ 5 units are common and may or may not result in early or late anaemia. In children who recovered from acute falciparum malaria-associated anaemia following ACTs, decline in haematocrit deficit is mono-exponential. TRIALS REGISTRATION: Pan African Clinical Trial Registry PACTR201508001188143, 3 July 2015; PACTR201508001191898, 7 July 2015 http://www.pactr.org. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-015-1219-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4620624 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46206242015-10-27 Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children Sowunmi, Akintunde Akano, Kazeem Ayede, Adejumoke I. Ntadom, Godwin Fatunmbi, Bayo Aderoyeje, Temitope Adewoye, Elsie O. BMC Infect Dis Research Article BACKGROUND: Artemisinin-based combination treatments (ACTs) or intravenous artesunate are used in over 100 countries for uncomplicated or severe falciparum malaria. Although intravenous artesunate may cause delayed haemolytic anaemia, there is little evaluation of the temporal changes in haematocrit following ACTs. METHODS: Clinical and parasitological parameters were measured before and following treatment of uncomplicated falciparum malaria in children with artesunate-amodiaquine (AA) or artemether-lumefantrine (AL) over 6-weeks. Changes in haematocrit were characterized in individual patients based on a haematocrit <30 % or ≥30 % before and following treatment. Kinetics of the deficit in haematocrit from <30 % until attainment of ≥30 % were estimated by a non-compartment model. RESULTS: In 248 of 1180 children eligible for evaluation, common temporal patterns were: no change or increase in haematocrit from ≥ 30 % [50 % of patients], haematocrit >30 % at presentation declining to <30 % within 2 weeks (early monophasic fall) [19 % of patients], and haematocrit <30 % at presentation increasing to ≥ 30 % [23 % of patients]. Haematocrit >30 % at presentation declining to <30 %, 3–5 weeks later (late monophasic fall) occurred in 7 children (3 %). Fall in haematocrit ≥5 units following treatment occurred in 57 children [23 %] between 14 and 28 days after treatment began. Baseline parasitaemia and proportion with > 100,000μL(-1 )asexual forms were significantly higher in children with ≥5 units compared to <5 units fall in haematocrit 21 or 28 days after treatment began. Irrespective of pattern, declines in haematocrit deficit from <30 % were mono-exponential, with similar half-times for AA- and AL-treated children (1.32 d versus 1.14 d). Anaemia half-time correlated significantly positively with anaemia recovery time in the same patients (r = 0.55, P < 0.0001). Bland-Altman analysis of 9 or 10 multiples of anaemia half-time and anaemia recovery times showed narrow limit of agreement with insignificant biases (P = 0.19 or 0.63, respectively). CONCLUSIONS: In uncomplicated falciparum malaria, increases or falls in haematocrit are common following ACTs. Falls in haematocrit ≥ 5 units are common and may or may not result in early or late anaemia. In children who recovered from acute falciparum malaria-associated anaemia following ACTs, decline in haematocrit deficit is mono-exponential. TRIALS REGISTRATION: Pan African Clinical Trial Registry PACTR201508001188143, 3 July 2015; PACTR201508001191898, 7 July 2015 http://www.pactr.org. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-015-1219-y) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-26 /pmc/articles/PMC4620624/ /pubmed/26502714 http://dx.doi.org/10.1186/s12879-015-1219-y Text en © Sowunmi et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Sowunmi, Akintunde Akano, Kazeem Ayede, Adejumoke I. Ntadom, Godwin Fatunmbi, Bayo Aderoyeje, Temitope Adewoye, Elsie O. Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children |
title | Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children |
title_full | Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children |
title_fullStr | Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children |
title_full_unstemmed | Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children |
title_short | Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children |
title_sort | temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620624/ https://www.ncbi.nlm.nih.gov/pubmed/26502714 http://dx.doi.org/10.1186/s12879-015-1219-y |
work_keys_str_mv | AT sowunmiakintunde temporalchangesinhaematocritfollowingartemisininbasedcombinationtreatmentsofuncomplicatedfalciparummalariainchildren AT akanokazeem temporalchangesinhaematocritfollowingartemisininbasedcombinationtreatmentsofuncomplicatedfalciparummalariainchildren AT ayedeadejumokei temporalchangesinhaematocritfollowingartemisininbasedcombinationtreatmentsofuncomplicatedfalciparummalariainchildren AT ntadomgodwin temporalchangesinhaematocritfollowingartemisininbasedcombinationtreatmentsofuncomplicatedfalciparummalariainchildren AT fatunmbibayo temporalchangesinhaematocritfollowingartemisininbasedcombinationtreatmentsofuncomplicatedfalciparummalariainchildren AT aderoyejetemitope temporalchangesinhaematocritfollowingartemisininbasedcombinationtreatmentsofuncomplicatedfalciparummalariainchildren AT adewoyeelsieo temporalchangesinhaematocritfollowingartemisininbasedcombinationtreatmentsofuncomplicatedfalciparummalariainchildren |